| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.067 | 0.1 |